Philip Lyng Madsen: Re-thinking how patients can contribute to research

Send us a text

After a successful career as a strategy consultant, Philip is attracted by the higher purpose of the life sciences space and takes on a quest to find solutions for why clinical trial timelines are growing longer and more complex. Even though his project is still in stealth mode, Philip takes Sam and Ivanna through some of the reasons he has uncovered so far.

We speak about the apprehension in the industry of trying new things, and how different roles in clinical trials perceive some of the same problems from different angles. We dive into recruitment of patients for clinical trials and how patient empowerment is changing how we engage with the health system. 

We imagine a fusion of research and treatment where trial treatment could be integrated into the treatment options patients are met with in the primary care - or even consider an opt-out model for contributing data for science. 

"Everyone with a condition should be able to contribute to finding a cure"
- Philip Lyng Madsen

Notes:

Guest Philip Lyng Madsen: https://www.linkedin.com/in/philiplyng/ 

Medicon Valley Alliance: https://mva.org/ 

Abbreviations: 

CRO: Clinical Research Organization 

IRB: Institutional Review Board

PI: Principal Investigator 

POC: Proof of Concept

________
Reach out to Ivanna Rosendal

Join the conversation on our LinkedIn page